You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 1 No. 3, September 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (56)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Acquired and Crossed Tolerance to Mescaline, LSD-25, and BOL-148

ANTONIO BALESTRIERI, M.D., L.D.; DIEGO FONTANARI, M.D., L.D.

AMA Arch Gen Psychiatry 1959;1(3):279-282.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It has been demonstrated experimentally that tolerance to the effects of lysergic acid diethylamide (LSD-25) develops rapidly, both in man1,4,6 and in animals.5 Tolerance to mescaline, with a less rapid development, was observed in rats by Freedman et al.5 We are not aware of studies on tolerance to 2-bromo-d-lysergic acid diethylamide (BOL-148). Tachyphylaxis to LSD-25, it seems, is another problem which has yet to be investigated.

In a previous research3 performed by our group crossed tolerance was demonstrated, in three human subjects, between LSD-25 and mescaline. The purpose of the present study was to confirm our experimental results and to investigate whether rapid tolerance to mescaline also develops in humans, whether subjects having acquired such tolernce are resistant to LSD-25, whether protracted administration of BOL-148 gives a tolerance to this drug and to the chemically related LSD-25, and whether . . . [Full Text PDF of this Article]


Author Affiliations

Padua, Italy


Footnotes

Submitted for publication Oct. 29, 1958.

Presented at the First International Meeting of Neuro-Psychopharmacology, Rome, Sept. 8-12, 1958.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.